Assetto Corsa Rally is out now, and players are diving into the high-octane tracks of Alsace and Wales as they race to set the fastest lap or compete in weekends. However, some gamers have reported ...

A strike is when more than 25 per cent of shareholders are against a company proposal, in this case executive pay, paving the way for a second ballot on whether to spill the board. Shareholders have ...

As an Amazon Associate, we earn from qualifying purchases. TweakTown may also earn commissions from other affiliate partners at no extra cost to you. For cross-platform compatibility, the Fanatec GT ...

Sim racing enthusiasts have a lot to look forward to, as Fanatec, a brand under Corsair and a leader in sim racing hardware, recently unveiled the next evolution of its flagship Podium Series at this ...

Fanatec has introduced a fresh addition to its CSL lineup — the CSL Steering Wheel GT3, an Xbox-licensed, GT3-inspired wheel aimed at delivering a realistic racing experience without breaking the bank ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Australian biotechnology ...

Asetek joins the entry-level direct drive market with its new Initium line up. If you can get past the looks of the wheel rim, Asetek offer a well rounded package with plenty of upgrade options, and ...

Cochin University of Science and Technology (Cusat) and Cochin Shipyard Limited (CSL) have signed a memorandum of understanding (MoU) to establish a centre of excellence in sustainable shipbuilding ...

Melbourne-headquartered CSL, a global biotechnology business specialising in bloods, vaccines and plasma products, on Tuesday revealed it will slash about 15 per cent of its staff in a sweeping ...

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure. The Melbourne-headquartered company will ...

SYDNEY—Vaccine and blood-products company CSL on Tuesday unveiled a sweeping corporate restructure that will include spinning off its flu-vaccine unit Seqirus and cutting up to 15% of its staff.